Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2026
MWN-AI** Summary
Kewaunee Scientific Corporation (NASDAQ: KEQU) has announced its plans to release financial results for the third quarter of fiscal year 2026 on Wednesday, March 11, 2026, following the close of trading. Investors and interested parties will be able to access the results on the company's official website, www.kewaunee.com, once they are published.
Founded in 1906, Kewaunee Scientific is a global leader in the design, manufacture, and installation of laboratory and technical furniture products. The company offers a wide range of products, including steel and wood casework, fume hoods, modular systems, biological safety cabinets, and specialized laboratory work surfaces. Headquartered in Statesville, North Carolina, Kewaunee has a strong domestic and international presence with sales offices in the U.S., India, Saudi Arabia, and Singapore, and with manufacturing plants located both domestically and in Bangalore, India.
A key development for Kewaunee has been its recent acquisition of Nu Aire, a recognized manufacturer of laboratory products such as CO2 incubators and ultralow freezers. This strategic addition aims to enhance Kewaunee's portfolio and address the needs of its clients more effectively.
In its communications, Kewaunee Scientific has provided caution regarding forward-looking statements about its future business operations and financial conditions, acknowledging that various factors, including market conditions and supply chain disruptions, could influence the accuracy of its projections. Investors are encouraged to review the company's detailed risk factors in its Annual Report and quarterly filings for a comprehensive understanding of potential risks.
For more updates, stakeholders can stay connected through Kewaunee's investor relations webpage.
MWN-AI** Analysis
As Kewaunee Scientific Corporation (NASDAQ: KEQU) prepares to release its third-quarter fiscal year 2026 results on March 11, investors should consider several critical factors shaping the company's performance and broader market context. Founded over a century ago, Kewaunee specializes in scientific, laboratory, and healthcare furniture products. The recent acquisition of Nu Aire expands Kewaunee’s reach into essential laboratory equipment, including biological safety cabinets, which could enhance revenue streams.
When analyzing Kewaunee's upcoming earnings, attention should be directed toward potential supply chain disruptions and international market dynamics, particularly given the company's global operations. Increased government regulations and economic conditions can significantly affect demand, especially in the healthcare sector, where Kewaunee’s products are key. Any commentary on how the acquisition of Nu Aire has contributed to current performance will be crucial. Analysts will look for synergies realized from this acquisition and whether Kewaunee has been able to leverage its manufacturing capabilities effectively.
Market sentiment regarding Kewaunee will also depend on the company's ability to manage rising raw material costs and any operational disruptions that may arise from geopolitical tensions or natural disasters. Forward-looking statements will likely reflect management's confidence in meeting upcoming challenges, but they can be laden with uncertainties.
Overall, investors should assess the stock's valuation relative to its projected growth, especially against its competitors in the laboratory furniture and equipment sector. If Kewaunee can deliver solid results that surpass market expectations and provide a positive outlook for growth, it may be an opportune moment for investors to consider entering or accumulating position in KEQU, considering its strong market foundation and expanding portfolio in essential laboratory products.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
STATESVILLE, N.C., Feb. 25, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its third quarter fiscal year 2026 financial results on Wednesday, March 11, 2026 after the close of trading. This information will be available on the Company's website www.kewaunee.com after the release.
About Kewaunee Scientific
Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The Company's corporate headquarters are located in Statesville, North Carolina. Sales offices are located in the United States, India, Saudi Arabia, and Singapore. Three manufacturing facilities are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets.
Kewaunee Scientific's newly acquired subsidiary, Nu Aire, is a leading manufacturer of biological safety cabinets, CO2 incubators, ultralow freezers, and other essential laboratory products that complement the Kewaunee Scientific portfolio. Founded in 1971, Nu Aire's headquarters and manufacturing facilities are located in Plymouth, Minnesota, with additional manufacturing capabilities located in Long Lake, Minnesota. The Company also maintains a warehouse partnership in the Netherlands and OEM partnerships in China.
Learn more at the companies' websites, located at http://www.kewaunee.com and http://www.nuaire.com/.
This press release contains statements that the Company believes to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company's future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "predict," "believe" and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other important factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. Such factors, risks, uncertainties and assumptions include, but are not limited to: our ability to realize the benefits anticipated as a result of the Nu Aire acquisition; competitive and general economic conditions, including disruptions from government mandates, both domestically and internationally, as well as supplier constraints and other supply disruptions; changes in customer demands; technological changes in our operations or in our industry; dependence on customers' required delivery schedules; risks related to fluctuations in the Company's operating results from quarter to quarter; risks related to international operations, including foreign currency fluctuations; changes in the legal and regulatory environment; changes in raw materials and commodity costs; acts of terrorism, war, governmental action, and natural disasters and other Force Majeure events. The cautionary statements made pursuant to the Reform Act herein and elsewhere by us should not be construed as exhaustive. We cannot always predict what factors would cause actual results to differ materially from those indicated by the forward-looking statements. Over time, our actual results, performance, or achievements will likely differ from the anticipated results, performance or achievements that are expressed or implied by our forward-looking statements, and such difference might be significant and harmful to our stockholders' interest. Many important factors that could cause such a difference are described under the caption "Risk Factors," in Item 1A of our Annual Report on Form 10-K for the fiscal year ended April 30, 2025, which you should review carefully, and in our subsequent quarterly reports on Form 10-Q and current reports on Form 8-K. These reports are available on our investor relations website at www.kewaunee.com and on the SEC website at www.sec.gov. These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact: | Donald T. Gardner III |
704/871-3274 |
SOURCE Kewaunee Scientific Corporation
FAQ**
What specific financial metrics is Kewaunee Scientific Corporation KEQU anticipating for the third quarter of fiscal year 2026, and how do these compare to previous quarters?
How has the acquisition of Nu Aire impacted Kewaunee Scientific Corporation KEQU's product offerings and overall profitability since it was completed?
What strategies is Kewaunee Scientific Corporation KEQU implementing to mitigate risks from supply chain disruptions and fluctuating raw material costs in the upcoming quarters?
How does Kewaunee Scientific Corporation KEQU plan to address changing customer demands and technological advancements within the laboratory and healthcare furniture markets?
**MWN-AI FAQ is based on asking OpenAI questions about Kewaunee Scientific Corporation (NASDAQ: KEQU).
NASDAQ: KEQU
KEQU Trading
0.63% G/L:
$41.69 Last:
2,042 Volume:
$42.29 Open:
